Next Article in Journal
Effects of Magnanimous Therapy on Coping, Adjustment, and Living Function in Advanced Lung Cancer
Previous Article in Journal
Efficacy and Safety of Combined Androgen Blockade with Antiandrogen for Advanced Prostate Cancer
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Palliative Care Consultation and Aggressive Care at End of Life in Unresectable Pancreatic Cancer

1
Division of Palliative Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
2
Department of Community Health and Epidemiology, Dalhousie University, Halifax, NS, Canada
3
Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Dalhousie University, 1276 South Park Street, Halifax, NS B3H 2Y9, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(1), 28-36; https://doi.org/10.3747/co.26.4389
Submission received: 3 November 2018 / Revised: 4 December 2018 / Accepted: 12 January 2019 / Published: 1 February 2019

Abstract

Background: Palliative care (pc) consultation has been associated with less aggressive care at end of life in a number of malignancies, but the effect of the consultation timing has not yet been fully characterized. For patients with unresectable pancreatic cancer (upcc), aggressive and resource-intensive treatment at the end of life can be costly, but not necessarily of better quality. In the present study, we investigated the association, if any, between the timing of specialist pc consultation and indicators of aggressive care at end of life in patients with upcc. Methods: This retrospective cohort study examined the potential effect of the timing of specialist pc consultation on key indicators of aggressive care at end of life in all patients diagnosed with upcc in Nova Scotia between 1 January 2010 and 31 December 2015. Statistical analysis included univariable and multivariable logistic regression. Results: In the 365 patients identified for inclusion in the study, specialist pc consultation was found to be associated with decreased odds of experiencing an indicator of aggressive care at end of life; however, the timing of the consultation was not significant. Residency in an urban area was associated with decreased odds of experiencing an indicator of aggressive care at end of life. We observed no association between experiencing an indicator of aggressive care at end of life and consultation with medical oncology or radiation oncology. Conclusions: Regardless of timing, specialist pc consultation was associated with decreased odds of experiencing an indicator of aggressive care at end of life. That finding provides further evidence to support the integral role of pc in managing patients with a life-limiting malignancy.
Keywords: pancreatic cancer; palliative care; aggressive care pancreatic cancer; palliative care; aggressive care

Share and Cite

MDPI and ACS Style

Lees, C.; Weerasinghe, S.; Lamond, N.; Younis, T.; Ramjeesingh, R. Palliative Care Consultation and Aggressive Care at End of Life in Unresectable Pancreatic Cancer. Curr. Oncol. 2019, 26, 28-36. https://doi.org/10.3747/co.26.4389

AMA Style

Lees C, Weerasinghe S, Lamond N, Younis T, Ramjeesingh R. Palliative Care Consultation and Aggressive Care at End of Life in Unresectable Pancreatic Cancer. Current Oncology. 2019; 26(1):28-36. https://doi.org/10.3747/co.26.4389

Chicago/Turabian Style

Lees, C., S. Weerasinghe, N. Lamond, T. Younis, and Ravi Ramjeesingh. 2019. "Palliative Care Consultation and Aggressive Care at End of Life in Unresectable Pancreatic Cancer" Current Oncology 26, no. 1: 28-36. https://doi.org/10.3747/co.26.4389

Article Metrics

Back to TopTop